Anika Therapeutics, Inc. (ANIK) News
Follow Anika Therapeutics, Inc. (ANIK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Anika Therapeutics Insider Sells 2,000 Shares
Anika Therapeutics insider sells shares
EQUITY | Aug 05, 2026, 08:31 PM UTC
L
US Stocks Rise After Earnings Reports
US stocks gain after earnings reports
EARNINGS | Jul 29, 2026, 01:05 PM UTC
L
Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est
Anika Therapeutics (NASDAQ: ANIK ) raises FY2026 sales outlook from $114.000 million-$122.500 million to $118.460 million-$124.101 million vs $118.612 million estimate.
EARNINGS | Jul 29, 2026, 11:10 AM UTC
L
ANIK Anika Therapeutics RESULTS: Q2, Q2 REV $32.61M, Q2 pretax profit $3.38M, Q2 gross profit $21.244M, Q2 Income from operations $2.954M, Q
ANIK Anika Therapeutics RESULTS: Q2, Q2 REV $32.61M, Q2 pretax profit $3.38M, Q2 gross profit $21.244M, Q2 Income from operations $2.954M, Q2 Net Income $3.309M
EARNINGS | Jul 29, 2026, 11:09 AM UTC
L
ANIK - Anika Reports Second Quarter 2026 Financial Results
ANIK - Anika Reports Second Quarter 2026 Financial Results
EARNINGS | Jul 29, 2026, 11:05 AM UTC